Top 12 Analyst Upgrades and Downgrades: FedEx, GE, Ulta Salon and Walmart

Photo of Jon C. Ogg
By Jon C. Ogg Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street and from boutique firms to find great ideas in value stocks, growth stocks and dividend stocks. Some are stocks to buy, while some ideas are even stocks to sell. These are ten of the top analyst upgrades, downgrades and initiations seen from select Wall Street research calls this Tuesday.

Canadian Pacific Railway Ltd. (NYSE: CP) was cut to Underperform from Sector Perform at RBC Capital Markets.

Equinix Inc. (NASDAQ: EQIX) was maintained for a fresh 12-month term on the US 1 List at BofA/Merrill Lynch.

FedEx Corp. (NYSE: FDX) was reiterated Buy and the target price was raised to $120 from $115 at BofA/Merrill Lynch.

General Electric Co. (NYSE: GE) was reiterated as Buy with $25 price target after getting a Systematically Important Financial Institution designation, according to BofA/Merrill Lynch.

Monolithic Power Systems Inc. (NASDAQ: MPWR) was started as Outperform at Wells Fargo.

PVH Corp. (NYSE: PVH) was cut to an Outperform from the Top Pick at RBC Capital Markets.

Rigel Pharmaceuticals Inc. (NASDAQ: RIGL) was cut to Neutral from Overweight at Piper Jaffray.

SeaWorld Entertainment Inc. (NYSE: SEAS) was started as Outperform at Wells Fargo.

Ulta Salon, Cosmetics & Fragrance Inc. (NASDAQ: ULTA) was cut to Neutral from Buy but with a $98 price target rather than the prior $93 target by Goldman Sachs.

Wal-Mart Stores Inc. (NYSE: WMT) was reiterated as Buy with $90 price target ahead of annual meeting at BofA/Merrill Lynch.

Credit Suisse on biotech and ASCO cancer stocks:

At ASCO, we saw promising Phase I data for four antibody drug conjugates. We believe this is the front of a very big wave of new drugs, and in our view, the best positioned biotech companies are Seattle Genetics Inc. (NASDAQ: SGEN) and ImmunoGen, Inc. (NASDAQ: IMGN), and on the pharma side, Roche.

Jefferies offers a list of consumer retail stocks to buy.

Photo of Jon C. Ogg
About the Author Jon C. Ogg →

Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. a673b.bigscoots-temp.com.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618